-
-
Call more information
660-596-2224 -
Patsy Newitt – 23 hours ago Author: Patsy Newitt Becker’s ASC Review Four anesthesia practices are suing CMS and HHS, among other parties, alleging CMS’ methodology for calculating reimbursements is illegal in its inclusion of costs associated with nonphysician practitioners. The suit, filed Dec. 18 by U.S. Anesthesia Partners of Texas, U.S. Anesthesia Partners of Florida, U.S. Anesthesia […]
Read MoreFrom Cardiac Anesthesiologist Hypernatremia and the resulting hyperosmolar state impact various bodily functions. One well-known consequence is its influence on neurological function. The occurrence of hypernatremia and subsequent hyperosmolality triggers a movement of free water from within cells to the extracellular space. This shift results in the shrinkage of brain cells, potentially leading to vascular […]
Read MoreASA Monitor January 2024, Vol. 88, 8–9. Your next patient in the preoperative clinic is a 68-year-old woman scheduled to undergo an L4-5 laminectomy for chronic back pain. She had a stroke one week ago, and you are considering how long to delay this elective surgery. A recent study of older adult patients showed the risk […]
Read MoreAuthors: Matthew T. Popovich, PhD et al ASA Monitor January 2024, Vol. 88, 28–29. Although anesthesiologists have always paid attention to blood pressure and its effects on both immediate and postoperative patient outcomes, only recently have anesthesiologists had better definitions and criteria to assess management of a patient’s blood pressure. The question for anesthesiologists and their […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review For ASCs, providing anesthesia in 2023 was a huge obstacle amid provider shortages and declining reimbursements. “Today’s shortage of anesthesia providers has been compounding for years and has turned into an incredible challenge for all,” Andrew Lovewell, CEO of Columbia (Mo.) Orthopaedic Group, told Becker’s. “Not only is it difficult to […]
Read MoreNew treatment for rare blood cancer The U.S. Food and Drug Administration (FDA) has approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) who have an isocitrate dehydrogenase-1 (IDH1) mutation. MDS is a rare form of blood cancer caused by mutations in bone marrow cells, leading to a […]
Read MoreAuthors: Zachariah P.G. Olufs, B.S. et al Anesthesiology December 2023. Background Carriers of mutations in the mitochondrial electron transport chain (mETC) are at increased risk of anesthetic-induced neurotoxicity. To investigate the neurotoxicity mechanism and to test preconditioning as a protective strategy, we used a Drosophila melanogaster model of Leigh syndrome. Model flies carried a mutation in ND23 (ND2360114) that encodes […]
Read MoreAUTHORS: Fritz, Bradley A. MD, MSCI et al Anesthesia & Analgesia June 2023. BACKGROUND: Machine learning models can help anesthesiology clinicians assess patients and make clinical and operational decisions, but well-designed human-computer interfaces are necessary for machine learning model predictions to result in clinician actions that help patients. Therefore, the goal of this study […]
Read MoreAuthors: Dinesh Ramaiah MBBS et al O THE EDITOR We appreciate the reprinting in the APSF Newsletter of the article from Anesthesia & Analgesia, (June 2022 • Volume 134 • Number 6, pages 1192–1200), entitled “Pro-Con Debate: Monitored Anesthesia Care Versus General Endotracheal Anesthesia for Endoscopic Retrograde Cholangiopancreatography” by Janik et al., and we hope that in reprinting […]
Read MoreAuthors: Aalok V. Agarwala, MD, MBA et al The transition of responsibility and accountability for patient care from one clinical team to another is a routine part of modern health care delivery. Whether between physical locations (e.g., from the emergency department to an inpatient floor), or between teams in a static location (e.g., from a […]
Read More